ADA 2025 20 - 23 June 2025

Amycretin, a Novel, Unimolecular GLP-1 and Amylin Receptor Agonist: Results of a Phase 1b/2a Clinical Trial

Authors :

Kirsten Dahl¹; Kasper Adelborg²; Sohan Dey³; Ruben Duque do Vale²; Cassandra Key⁴; Søren Toubro²; Ania M. Jastreboff⁵

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Obesity

Congress poster

GLP-1 RA

Amylin analogue

Amycretin

PHASE 1 (RCT)

PHASE 2 (RCT)